Brain Implants Market Share, Size, Growth Drivers and Outlook
[Research Report] The brain implants market size is projected to grow from US$ 7,205.80 million in 2022 to US$ 17,647.65 million by 2030; it is projected to record a CAGR of 11.8% during 2022-2030.
Market Insights and Analyst View:
Neuroscience and neurotechnology are advancing rapidly, pushing medical science to new limits as neurological diseases such as Parkinson's, Alzheimer's, and epilepsy have become more common. Brain implants offer potential therapeutic solutions by modifying neural activity and restoring normal brain function. In addition, people have become more aware of the advantages of brain implants. Growing reliance on deep brain stimulation as a safe and proven treatment for Parkinson's creates growth opportunities for the brain implants market. The market is expected to experience further growth in the coming years with the introduction and use of a larger number of neural implants to help with memory improvement, disease treatment, and prosthetic limb communication to effectively mitigate the symptoms of brain-related disorders.
Growth Drivers:
With age, elderly people are likely to develop neurological disorders that impact their mobility. Alzheimer's disease, epilepsy, Parkinson’s disease (PD), and dystonia are among the most common neurological disorders affecting the geriatric population. According to the 2020 population statistics by the US Census Bureau, the geriatric population reached 55.8 million, i.e., 16.8% of the national population; nearly 1 in 6 people in the country were aged 65 and above in 2020. Further, according to the data from the Pan American Health Organization (PAHO), Brazil has ~30 million people aged 60 and above (i.e., 13% of the country's population). The population of this age group is further expected to reach ~50 million (i.e., 24% of the total population) by 2030. According to an article published by UpToDate Inc. in August 2021, epilepsy incidence rises with age and is highest among patients aged 75 and above.
Countries such as the US and Canada have high prevalence rates of movement disorders and psychiatric disorders associated with growing geriatric populations. According to the Parkinson's Foundation, Parkinson's symptoms are common at an average age of 60. For instance, ~90,000 Americans are diagnosed with PD yearly. The organization also states that the incidence of PD increases with age; nearly 1 million people in the US are living with PD, and the number is expected to reach 1.2 million by 2030. According to an article titled “Alzheimer's disease: Can deep brain stimulation help alleviate symptoms?” published in April 2023, ~32 million people worldwide have Alzheimer’s disease. As per the Alzheimer's Disease Research Factsheet, published by BrightFocus Foundation in October 2022, ~500,000 new cases of Alzheimer's disease were diagnosed in 2022 in the US. The incidence rate of Alzheimer's increases with age. ~6.5 million Americans aged 65 and above are suffering from Alzheimer's disease, and the number is expected to reach 12.7 million by 2050. According to the World Health Organization (WHO) stats released in February 2022, approximately 50 million people suffer from epilepsy, which is one of the most common neurological diseases worldwide.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Brain Implants Market: Strategic Insights
Market Size Value in US$ 7,205.80 million in 2022 Market Size Value by US$ 17,647.65 million by 2030 Growth rate CAGR of 11.8% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Brain Implants Market: Strategic Insights
| Market Size Value in | US$ 7,205.80 million in 2022 |
| Market Size Value by | US$ 17,647.65 million by 2030 |
| Growth rate | CAGR of 11.8% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The increasing incidence of neurological diseases, coupled with the growing geriatric population, drives the demand for brain implants to treat and manage the disease. The deep brain stimulation (DBS) technique is used to treat epilepsy cases due to the low therapeutic response exhibited by the patient’s body to medication during seizures and reduced success rates associated with surgeries. Researchers from the University of North Carolina at Chapel Hill claim to have generated new neurons in the brain, which can be stimulated using DBS. DBS for Alzheimer's involves utilizing an implanted device similar to a heart pacemaker and two attached wires that deliver mild electrical pulses directly to the fornix area of the brain. Electrical stimulation can activate the memory circuitry in the brain to sharpen its function. Thus, neural implants such as DBS and vagus nerve stimulation are increasingly being used to treat patients with PD and other neurological conditions.
Report Segmentation and Scope:
The brain implants market is segmented on the basis of treatment, application, end user, and geography. Based on treatment, the market is segmented into deep brain stimulation, spinal cord stimulator, vagus nerve stimulator, invasive and noninvasive brain–computer interfaces, responsive neurostimulation for seizures, auditory brainstem implant, and ophthalmic aids/implant. Based on application, the market is categorized into chronic pain, Parkinson’s disease, Alzheimer’s disease, epilepsy, essential tremor, depression, dystonia, amyotrophic lateral sclerosis/stroke/spinal cord injury, and neurofibromatosis 2/total ossification of the cochlea. In terms of end user, the brain implants market is bifurcated into hospitals and specialized clinics/neurological centers. The brain implants market, based on geography, is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Segmental Analysis:
The brain implants market, by treatment, is segmented into deep brain stimulation, spinal cord stimulator, vagus nerve stimulator, invasive and noninvasive brain–computer interfaces, responsive neurostimulation for seizures, auditory brainstem implant, and ophthalmic aids/implant. The spinal cord stimulator segment held the largest share of the market in 2022. However, the invasive and noninvasive brain–computer interfaces segment is estimated to register the highest CAGR in the market during 2022–2030. Spinal cord stimulation (SCS) can help manage chronic pain when the cause cannot be entirely treated using conventional methods, or the injury cannot be repaired. This therapy offers relief and improves the daily functioning of patients suffering from chronic pain. It is indicated for the management of chronic, intractable pain of the trunk, including unilateral or bilateral pain. Furthermore, SCS helps in targeted pain relief. SCS devices are available in different varieties that can be used as an alternative to other sorts of treatments, such as opioids, to which patients can develop addiction.
According to a report published by the National Spinal Cord Injury Statistical Center in June 2021, a spinal cord injury is thought to affect nearly 296,000 persons in the US. The demand for spinal cord stimulators is likely to rise with the increasing cases of spinal cord illness. Thus, the elevated incidences of spinal illnesses and chronic lower back pain, in combination with the availability of medical reimbursements, favors the growth of the brain implants market for the SCS segment.
Based on application, the brain implants market is segmented into chronic pain, Parkinson’s disease, Alzheimer’s disease, epilepsy, essential tremor, depression, dystonia, amyotrophic lateral sclerosis/stroke/spinal cord injury, and neurofibromatosis 2/total ossification of the cochlea. The chronic pain segment held the largest market share in 2022. The Alzheimer’s disease segment is expected to register the highest CAGR during 2022–2030. Chronic pain refers to persistent or recurring pain that persists beyond the average healing time of an injury or illness, usually persisting for more than 3–6 months. It can result from various underlying conditions and can affect any part of the body. Chronic pain is a complex and multifaceted condition having a significant impact on the physical and emotional well-being, quality of life, and daily functioning of people. Managing chronic pain can be challenging as it often involves a combination of treatments—including medication, physical therapy, lifestyle changes, and psychological interventions. According to UCSF estimates, 1 in 4 persons in the US were experiencing chronic pain in 2020, and many of them were resistant to therapy. People who have pain from spinal injuries, post-stroke pain, phantom limb pain, nerve pain, and other illnesses frequently experience misery without much hope for treatment.
Brain implant technologies have been explored as an alternative approach for controlling and alleviating chronic pain in cases that cannot be controlled effectively using conventional treatments. DBS is a type of brain implant that has been studied for its potential effectiveness in chronic pain management. In March 2022, the National Institutes of Health awarded the professors of neurological surgery and staff at the USCF Weill Institute for Neurosciences a five-year grant totaling US$ 7.56 million for an advanced DBS solution as a chronic pain treatment. It's 1 of 10 grants from the NIH's Helping to End Addiction Long-Term (HEAL) Initiative that is worth more than US$ 40 million. Thus, the increasing funding for research on chronic pain propels the brain implant market for this segment.
Based on end user, the brain implants market is bifurcated into hospitals and specialized clinics/neurological centers. The hospitals segment held a larger market share in 2022 and is anticipated to grow at a higher CAGR during 2022–2030. Hospitals are complex organizations that provide healthcare services by using complicated but specialized scientific equipment. They employ teams of professionals trained to address the problems of modern medical sciences. They are all coordinated together for the common goal of restoring and maintaining good health. As specialized healthcare facilities, hospitals have key set-ups for the diagnosis, treatment, and management of various neurological conditions that may require brain implant interventions. Hospitals provide pre-and post-operative care, which includes the assessment and selection of suitable candidates for brain implants. They also prompt continuous monitoring and programming and schedule follow-up visits to ensure the proper functioning of these implants, eventually optimizing outcomes for patients undergoing implantation procedures. Hospitals serve as centers of expertise, housing multidisciplinary teams of neurologists, neurosurgeons, nurses, and other healthcare professionals who collaborate to provide specialized care for patients receiving brain implants.
Hospitals play a pivotal role in conducting research and clinical trials to advance knowledge, improve technologies, and expand the applications of brain implant devices. They serve as educational and training centers, providing opportunities for healthcare professionals to enhance their expertise in brain implantation area through specialized training programs and continuous medical education.
Regional Analysis:
Based on geography, the brain implants market is primarily divided into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. North America captured a significant share of the global market in 2022. The US accounted for the largest share of the market in this region. The market growth in the US is attributed to the increasing prevalence of neurological diseases, rising research and development activities, and technological advancements in brain implants. According to the Parkinson's Foundation, 930,000 people in the US were suffering from PD in 2020, and the number is expected to increase to 1.2 million by 2030. Brain implants such as deep brain stimulators (DBS) have proven to be potential treatment options for PD. DBS devices have been observed to be effective in controlling tremors associated with PD. As per the Oregon Health & Science University (OSHU) Brain Institute, ~90% of patients with essential tremors in the US experienced moderate relief from symptoms after DBS.
Technological advancements and new product launches also drive the growth of the US brain implants market. In January 2020, Abbott's Infinity DBS System received US Food and Drug Administration (FDA) approval for treating PD. This system targets a specific area of the brain (the inner globus pallidus), which is associated with the symptoms of PD.
Brain Implants Market Report Scope
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the global brain implants market are listed below:
- In June 2023, Boston Scientific Corp received US FDA approval for the Vercise Neural Navigator 5 Software, which is used as part of the Vercise Genus Deep Brain Stimulation (DBS) Systems. It provides clinicians with simple and actionable data for efficient programming in the treatment of people living with Parkinson’s disease or essential tremor.
- In January 2021, Medtronic plc announced the enrollment in ADAPT-PD (Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease) to evaluate the safety and efficacy of adaptive DBS in patients with Parkinson's Disease.
Competitive Landscape and Key Companies:
Boston Scientific Corporation, Medtronic, Abbott (St. Jude Medical), Renishaw Plc., NeuroPace Inc., Aleva Neurotherapeutics, Functional Neuromodulation Inc., Fisher Wallace, NeuroSpine, Cortec Neuro, Neuro Sky, Neuralink, Synchron, Blackrock Neurotech, BrainGate, Wisper AI, Onward Medical, and Paradromics are among the prominent players in the brain implants market. These companies focus on introducing new high-tech products, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Treatment, Application, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The brain implants market was valued at US$ 7,205.80 million in 2022.
The brain implants market is expected to be valued at US$ 17,647.65 million in 2030.
Spinal cord stimulation (SCS) can help manage chronic pain when the cause cannot be entirely treated using conventional methods or the injury cannot be repaired. This therapy offers relief and improves the daily functioning of patients suffering from chronic pain; it uses a mild electrical current to stimulate specific nerve fibers in the spinal cord. It is indicated for the management of chronic, intractable pain of the trunk, including unilateral or bilateral pain. Furthermore, SCS helps in targeted pain relief. The method can improve the overall quality of life and sleep, and reduce the need for pain medicines. SCS devices are available in different varieties that can be used as an alternative to other sorts of treatments such as opioids, to which patients can develop addiction.
Neuroscience and neurotechnology are advancing rapidly, pushing medical science to new limits, driving the growth of the market, as neurological diseases like Parkinson's, Alzheimer's, and epilepsy become more common. Brain implants offer potential therapeutic solutions by modifying neural activity and restoring normal brain function. In addition, people have become more aware of the advantages of brain implants, and positive research outcomes are favoring brain implants market growth. Growing reliance on deep brain stimulation as a safe and proven treatment for Parkinson's creates growth opportunities for the brain implants market. The industry is expected to experience further growth in the coming years as more and more neural implants are being used to help with memory, disease treatment, and prosthetic limb communication to effectively reduce the symptoms of brain-related disorders.
The brain implants market has major market players, including Boston Scientific Corp, Medtronic Plc, Functional Neuromodulation Ltd, Fisher Wallace Laboratories Inc., Synchron Inc., Blackrock Microsystems Inc, Renishaw Plc., Abbott Laboratories, Neurospine LLC, CorTec GmbH, BrainGate, Aleva Neurotherapeutics SA, NeuroSky Inc, Neuralink Corp, NeuroPace Inc., ONWARD Medical NV, and Paradromics Inc.
Key factors driving the market growth are surging prevalence of neurological disorders with increasing geriatric population and rising number of spinal cords injuries. However, high cost associated with brain implant devices and procedures hinders the market growth.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Brain Implants Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Brain Implants Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Surging Prevalence of Neurological Disorders with Increasing Geriatric Population
5.1.2 Rising Number of Spinal Cord Injuries
5.2 Key Market Restraints
5.2.1 High Cost Associated with Brain Implant Devices and Procedures
5.3 Key Market Opportunities
5.3.1 Strategic Initiatives by Companies
5.4 Key Future Trends
5.4.1 Technological Advancements such as Miniaturization, Artificial Intelligence, and Modern Brain–Machine Interfaces
5.5 Impact Analysis:
6. Brain Implants Market - Global Market Analysis
6.1 Brain Implants Market Revenue (US$ Mn), 2022 – 2030
7. Global Brain Implants Market – Revenue and Forecast to 2030 – by Treatment.
7.1 Overview
7.2 Brain Implants Market Revenue Share, by Treatment, 2022 & 2030 (%)
7.3 Deep Brain Stimulation
7.3.1 Overview
7.3.2 Deep Brain Stimulation: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Spinal Cord Stimulation
7.4.1 Overview
7.4.2 Spinal Cord Stimulation: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Vagus Nerve Stimulator
7.5.1 Overview
7.5.2 Vagus Nerve Stimulator: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Invasive and Non-Invasive Brain-Computer Interfaces
7.6.1 Overview
7.6.2 Invasive and Non-Invasive Brain-Computer Interfaces: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Responsive Neurostimulation for Seizures
7.7.1 Overview
7.7.2 Responsive Neurostimulation for Seizures: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Auditory Brainstem Implant
7.8.1 Overview
7.8.2 Auditory Brainstem Implant: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
7.8.3 Retrocochlear Hearing Impairment
7.8.3.1 Retrocochlear Hearing Impairment: Auditory Brainstem Implants Market– Revenue and Forecast to 2030 (US$ Million)
7.8.4 Cochlear Hearing Impairment
7.8.4.1 Cochlear Hearing Impairment: Auditory Brainstem Implants Market– Revenue and Forecast to 2030 (US$ Million)
7.9 Ophthalmic Aids/Implant
7.9.1 Overview
7.9.2 Ophthalmic Aids/Implant: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Brain Implants Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Brain Implants Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Chronic Pain
8.3.1 Overview
8.3.2 Chronic Pain: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Parkinson's disease
8.4.1 Overview
8.4.2 Parkinson's disease: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Alzheimer's disease
8.5.1 Overview
8.5.2 Alzheimer's disease: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Epilepsy
8.6.1 Overview
8.6.2 Epilepsy: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Essential Tremor
8.7.1 Overview
8.7.2 Essential Tremor: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Depression
8.8.1 Overview
8.8.2 Depression: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.9 Dystonia
8.9.1 Overview
8.9.2 Dystonia: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.10 Amyotrophic Lateral Sclerosis
8.10.1 Overview
8.10.2 Amyotrophic Lateral Sclerosis (ALS): Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
8.11 Neurofibromatosis 2
8.11.1 Overview
8.11.2 Neurofibromatosis 2: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Brain Implants Market – Revenue and Forecast to 2030 – by End-User
9.1 Overview
9.2 Brain Implants Market Revenue Share, by End-User, 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Specialized Clinics / Neurological Centers
9.4.1 Overview
9.4.2 Specialized Clinics / Neurological Centers: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
10. Brain Implants Market - Geographical Analysis
10.1 North America Brain Implants Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3 North America: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.1.3.1 North America: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.1.4 North America: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.1.5 North America: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.1.5.1 North America Brain Implants Market, by Country
10.1.5.2 US
10.1.5.2.1 US Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.5.2.2 US: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.1.5.2.2.1 US: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.1.5.2.3 US: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.1.5.2.4 US: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.1.5.3 Canada
10.1.5.3.1 Canada Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.5.3.2 Canada: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.1.5.3.2.1 Canada: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.1.5.3.3 Canada: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.1.5.3.4 Canada: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.1.5.4 Mexico
10.1.5.4.1 Mexico Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.1.5.4.2 Mexico: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.1.5.4.2.1 Mexico: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.1.5.4.3 Mexico: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.1.5.4.4 Mexico: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.2 Europe Brain Implants Market, Revenue and Forecast to 2030
10.2.1 Overview
10.2.2 Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3 Europe: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.2.3.1 Europe: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.2.4 Europe: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.2.5 Europe: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.2.6 Europe Brain Implants Market, by Country
10.2.6.1 UK
10.2.6.1.1 UK Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.1.2 UK: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.2.6.1.2.1 UK: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.2.6.1.3 UK: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.2.6.1.4 UK: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.2.6.2 Germany
10.2.6.2.1 Germany Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.2.2 Germany: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.2.6.2.2.1 Germany: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.2.6.2.3 Germany: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.2.6.2.4 Germany: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.2.6.3 France
10.2.6.3.1 France Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.3.2 France: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.2.6.3.2.1 France: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.2.6.3.3 France: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.2.6.3.4 France: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.2.6.4 Italy
10.2.6.4.1 Italy Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.4.2 Italy: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.2.6.4.2.1 Italy: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.2.6.4.3 Italy: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.2.6.4.4 Italy: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.2.6.5 Spain
10.2.6.5.1 Spain Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.5.2 Spain: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.2.6.5.2.1 Spain: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.2.6.5.3 Spain: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.2.6.5.4 Spain: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.2.6.6 Rest of Europe
10.2.6.6.1 Rest of Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.6.2 Rest of Europe: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.2.6.6.2.1 Rest of Europe: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.2.6.6.3 Rest of Europe: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.2.6.6.4 Rest of Europe: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.3 Asia Pacific Brain Implants Market, Revenue and Forecast to 2030
10.3.1 Overview
10.3.2 Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3 Asia Pacific: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.3.3.1 Asia Pacific: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.3.4 Asia Pacific: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.3.5 Asia Pacific: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.3.6 Asia Pacific Brain Implants Market, by Country
10.3.6.1 China
10.3.6.1.1 China Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.1.2 China: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.3.6.1.2.1 China: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.3.6.1.3 China: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.3.6.1.4 China: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.3.6.2 Japan
10.3.6.2.1 Japan Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.2.2 Japan: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.3.6.2.2.1 Japan: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.3.6.2.3 Japan: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.3.6.2.4 Japan: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.3.6.3 India
10.3.6.3.1 India Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.3.2 India: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.3.6.3.2.1 India: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.3.6.3.3 India: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.3.6.3.4 India: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.3.6.4 Australia
10.3.6.4.1 Australia Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.4.2 Australia: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.3.6.4.2.1 Australia: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.3.6.4.3 Australia: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.3.6.4.4 Australia: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.3.6.5 South Korea
10.3.6.5.1 South Korea Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.5.2 South Korea: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.3.6.5.2.1 South Korea: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.3.6.5.3 South Korea: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.3.6.5.4 South Korea: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.3.6.6 Rest of Asia Pacific
10.3.6.6.1 Rest of Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.6.2 Rest of Asia Pacific: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.3.6.6.2.1 Rest of Asia Pacific: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.4 Middle East & Africa Brain Implants Market, Revenue and Forecast to 2030
10.4.1 Overview
10.4.2 Middle East & Africa Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3 Middle East & Africa: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.4.3.1 Middle East & Africa: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.4.4 Middle East & Africa: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.4.5 Middle East & Africa: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.4.6 Middle East & Africa Brain Implants Market, by Country
10.4.6.1 Saudi Arabia
10.4.6.1.1 Saudi Arabia Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.1.2 Saudi Arabia: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.4.6.1.2.1 Saudi Arabia: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.4.6.1.3 Saudi Arabia: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.4.6.1.4 Saudi Arabia: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.4.6.2 UAE
10.4.6.2.1 UAE Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.2.2 UAE: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.4.6.2.2.1 UAE: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.4.6.2.3 UAE: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.4.6.2.4 UAE: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.4.6.3 South Africa
10.4.6.3.1 South Africa Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.3.2 South Africa: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.4.6.3.2.1 South Africa: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.4.6.3.3 South Africa: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.4.6.3.4 South Africa: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.4.6.4 Rest of Middle East & Africa
10.4.6.4.1 Rest of Middle East & Africa Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.4.2 Rest of Middle East & Africa: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.4.6.4.2.1 Rest of Middle East & Africa: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.4.6.4.3 Rest of Middle East & Africa: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.5 South & Central America Brain Implants Market, Revenue and Forecast to 2030
10.5.1 Overview
10.5.2 South & Central America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3 South & Central America: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.5.3.1 South & Central America: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.5.4 South & Central America: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.5.5 South & Central America: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.5.6 South & Central America Brain Implants Market, by Country
10.5.6.1 Brazil
10.5.6.1.1 Brazil Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.1.2 Brazil: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.5.6.1.2.1 Brazil: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.5.6.1.3 Brazil: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.5.6.1.4 Brazil: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.5.6.2 Argentina
10.5.6.2.1 Argentina Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.2.2 Argentina: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.5.6.2.2.1 Argentina: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.5.6.2.3 Argentina: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.5.6.2.4 Argentina: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
10.5.6.3 Rest of South & Central America
10.5.6.3.1 Rest of South & Central America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.3.2 Rest of South & Central America: Brain Implants Market, by Treatment, 2020–2030 (US$ Million)
10.5.6.3.2.1 Rest of South & Central America: Brain Implants Market, by Auditory Brainstem Implants, 2020–2030 (US$ Million)
10.5.6.3.3 Rest of South & Central America: Brain Implants Market, by Application, 2020–2030 (US$ Million)
10.5.6.3.4 Rest of South & Central America: Brain Implants Market, by End-User, 2020–2030 (US$ Million)
11. Brain Implants Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in Brain Implants Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Boston Scientific Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Functional Neuromodulation Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 SWOT Analysis
12.3.5 Key Developments
12.4 Fisher Wallace Laboratories Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Synchron Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 SWOT Analysis
12.5.5 Key Developments
12.6 Blackrock Microsystems Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 SWOT Analysis
12.6.5 Key Developments
12.7 Renishaw Plc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Abbott Laboratories
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Neurospine LLC
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 SWOT Analysis
12.9.5 Key Developments
12.10 CorTec GmbH
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 SWOT Analysis
12.10.5 Key Developments
12.11 BrainGate
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 SWOT Analysis
12.11.5 Key Developments
12.12 Aleva Neurotherapeutics SA
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 SWOT Analysis
12.12.5 Key Developments
12.13 NeuroSky Inc
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 SWOT Analysis
12.13.5 Key Developments
12.14 Neuralink Corp
12.14.1 Key Facts
12.14.2 Business Description
12.14.3 Products and Services
12.14.4 SWOT Analysis
12.14.5 Key Developments
12.15 NeuroPace Inc
12.15.1 Key Facts
12.15.2 Business Description
12.15.3 Products and Services
12.15.4 Financial Overview
12.15.5 SWOT Analysis
12.15.6 Key Developments
12.16 ONWARD Medical NV
12.16.1 Key Facts
12.16.2 Business Description
12.16.3 Products and Services
12.16.4 Financial Overview
12.16.5 SWOT Analysis
12.16.6 Key Developments
12.17 Paradromics Inc
12.17.1 Key Facts
12.17.2 Business Description
12.17.3 Products and Services
12.17.4 SWOT Analysis
12.17.5 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
List of Tables
Table 1. Brain Implants Market Segmentation
Table 2. North America Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Brain Implants Market, by Auditory Brainstem Implants – Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5. North America Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 6. US Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 7. US Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 8. US Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 9. US Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13. Canada Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17. Mexico Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 18. Europe Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 19. Europe Brain Implants Market, by Auditory Brainstem Implants – Revenue and Forecast to 2030 (US$ Million)
Table 20. Europe Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 21. Europe Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 22. UK Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 23. UK Brain Implants Market, by Auditory Brainstem Implants – Revenue and Forecast to 2030 (US$ Million)
Table 24. UK Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 25. UK Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 26. Germany Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 27. Germany Brain Implants Market, by Auditory Brainstem Implants – Revenue and Forecast to 2030 (US$ Million)
Table 28. Germany Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 29. Germany Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 30. France Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 31. France Brain Implants Market, by Auditory Brainstem Implants – Revenue and Forecast to 2030 (US$ Million)
Table 32. France Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 33. France Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 34. Italy Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 35. Italy Brain Implants Market, by Auditory Brainstem Implants – Revenue and Forecast to 2030 (US$ Million)
Table 36. Italy Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 37. Italy Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 38. Spain Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 39. Spain Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 40. Spain Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 41. Spain Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 42. Rest of Europe Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 43. Rest of Europe Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 44. Rest of Europe Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 45. Rest of Europe Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 46. Asia Pacific Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 47. Asia Pacific Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 48. Asia Pacific Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 49. Asia Pacific Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 50. China Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 51. China Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 52. China Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 53. China Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 54. Japan Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 55. Japan Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 56. Japan Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 57. Japan Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 58. India Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 59. India Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 60. India Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 61. India Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 62. Australia Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 63. Australia Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 64. Australia Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 65. Australia Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 66. South Korea Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 67. South Korea Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 68. South Korea Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 69. South Korea Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 70. Rest of Asia Pacific Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 71. Rest of Asia Pacific Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 72. Rest of Asia Pacific Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 73. Rest of Asia Pacific Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 74. Middle East & Africa Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 75. Middle East & Africa Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 76. Middle East & Africa Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 77. Middle East & Africa Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 78. Saudi Arabia Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 79. Saudi Arabia Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 80. Saudi Arabia Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 81. Saudi Arabia Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 82. UAE Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 83. UAE Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 84. UAE Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 85. UAE Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 86. South Africa Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 87. South Africa Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 88. South Africa Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 89. South Africa Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 90. Rest of Middle East & Africa Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 91. Rest of Middle East & Africa Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 92. Rest of Middle East & Africa Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 93. Rest of Middle East & Africa Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 94. South & Central America Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 95. South & Central America Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 96. South & Central America Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 97. South & Central America Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 98. Brazil Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 99. Brazil Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 100. Brazil Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 101. Brazil Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 102. Argentina Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 103. Argentina Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 104. Argentina Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 105. Argentina Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 106. Rest of South & Central America Brain Implants Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 107. Rest of South & Central America Brain Implants Market, by Auditory Brainstem Implants– Revenue and Forecast to 2030 (US$ Million)
Table 108. Rest of South & Central America Brain Implants Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 109. Rest of South & Central America Brain Implants Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 110. Recent Organic Growth Strategies in Brain Implants Market
Table 111. Recent Inorganic Growth Strategies in the Brain Implants Market
Table 112. Glossary of Terms, Brain Implants Market
List of Figures
Figure 1. Brain Implants Market Segmentation, By Geography
Figure 2. Global - PEST Analysis
Figure 3. Brain Implants Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Brain Implants Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Brain Implants Market Revenue, Geography (US$ Mn), 2022 – 2030
Figure 7. Brain Implants Market Revenue Share, by Treatment, 2022 & 2030 (%)
Figure 8. Deep Brain Stimulation: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Spinal Cord Stimulation: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vagus Nerve Stimulator: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Invasive and Non-Invasive Brain-Computer Interfaces: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Responsive Neurostimulation for Seizures: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Auditory Brainstem Implant: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Ophthalmic Aids/Implant: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Ophthalmic Aids/Implant: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Ophthalmic Aids/Implant: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Brain Implants Market Revenue Share, by Application 2022 & 2030 (%)
Figure 18. Chronic Pain: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Parkinson's disease: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Alzheimer's disease: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Epilepsy: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Essential Tremor: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Depression: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Dystonia: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Amyotrophic Lateral Sclerosis (ALS): Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Neurofibromatosis 2: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Brain Implants Market Revenue Share, by End-User, 2022 & 2030 (%)
Figure 28. Hospitals: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Specialized Clinics / Neurological Centers: Brain Implants Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. North America: Brain Implants Market, by Key Country – Revenue (2022) (US$ Million)
Figure 31. North America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. North America Brain Implants Market, By Key Countries, 2022 and 2030 (%)
Figure 33. US Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Canada Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Mexico Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Europe Brain Implants Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 37. Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. Europe Brain Implants Market, By Key Countries, 2022 and 2030 (%)
Figure 39. UK Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 40. Germany Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. France Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 42. Italy Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Spain Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 44. Rest of Europe Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 45. Asia Pacific Brain Implants Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 46. Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 47. Asia Pacific Brain Implants Market, By Key Countries, 2022 and 2030 (%)
Figure 48. China Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 49. Japan Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 50. India Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 51. Australia Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 52. South Korea Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 53. Rest of Asia Pacific Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 54. Middle East & Africa Brain Implants Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 55. Middle East & Africa Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 56. Middle East & Africa Brain Implants Market, By Key Countries, 2022 and 2030 (%)
Figure 57. Saudi Arabia Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 58. UAE Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. South Africa Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 60. Rest of Middle East & Africa Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 61. South & Central America Brain Implants Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 62. South & Central America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 63. South & Central America Brain Implants Market, By Key Countries, 2022 and 2030 (%)
Figure 64. Brazil Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 65. Argentina Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 66. Rest of South & Central America Brain Implants Market Revenue and Forecast to 2030 (US$ Mn)
Figure 67. Growth Strategies in Brain Implants Market
The List of Companies - Brain Implants Market
- Boston Scientific Corp
- Medtronic Plc
- Functional Neuromodulation Ltd
- Fisher Wallace Laboratories Inc.
- Synchron Inc.
- Blackrock Microsystems Inc
- Renishaw Plc.
- Abbott Laboratories
- Neurospine LLC
- CorTec GmbH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For